DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Li G, Crowley MJ, Tang H. et al.
Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials.
Diabetes Care 2019;
42 (07) e119-e121
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.